Biochemical pharmacologyMaleHumansReceptorsAndrogenProstatic Neoplasms
A novel peptide explicitly induces prostate cancer cell death by destabilizing AR and inhibiting AR-mediated transcription.
Akanksha Agarwal, Aishani Patnaik, Ekta Gupta, Bharti Jaiswal, Ashish Gupta
Published: 202610.1016/j.bcp.2025.117616
Abstract
Current treatment strategies for prostate cancer primarily focuses on regulating androgen receptor (AR) activity, either through androgen deprivation or the use of anti-androgen therapies. While these approaches are initially effective, many patients…
Preview only. Read the full abstract at the source